Howard J. Weisman - Aug 28, 2023 Form 4 Insider Report for PaxMedica, Inc. (PXMD)

Role
Chairman and CEO, Director
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Stock symbol
PXMD
Transactions as of
Aug 28, 2023
Transactions value $
-$20,561
Form type
4
Date filed
8/30/2023, 04:09 PM
Previous filing
Jul 28, 2023
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale -$5.86K -12K -1.71% $0.49 690K Aug 28, 2023 Direct F1, F2
transaction PXMD Common Stock Sale -$4.65K -9.6K -1.39% $0.48 680K Aug 29, 2023 Direct F1, F3
transaction PXMD Common Stock Sale -$10.1K -22.5K -3.31% $0.45 658K Aug 30, 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
F2 The sale price represents the weighted average sale price of the shares sold ranging from $0.4702 to $0.5246 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The sale price represents the weighted average sale price of the shares sold ranging from $0.4844 to $0.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 The sale price represents the weighted average sale price of the shares sold ranging from $0.4101 to $0.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.